Skip to main content
logo
TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS · Delayed Price · Currency is USD
0.0055
+0.0054 (5,400.00%)
At close: Apr 1, 2026

TC Biopharm (Holdings) Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-12.15-5.91-1.31-13.58-5.46
Depreciation & Amortization
0.430.630.771.011.08
Other Amortization
-0-0.02-
Loss (Gain) From Sale of Assets
--0.01--
Asset Writedown & Restructuring Costs
0.13----
Stock-Based Compensation
1.010.441.12-0.8
Other Operating Activities
0.04-7.26-9.187.20.07
Change in Accounts Receivable
----0.591.73
Change in Accounts Payable
-0.612.27-1.942.340.33
Change in Unearned Revenue
---3.84-1.98-1.98
Change in Income Taxes
0.390.68-0.31--
Change in Other Net Operating Assets
-1.81-1.41-0.6--
Operating Cash Flow
-12.57-10.54-15.29-5.58-3.43
Capital Expenditures
-0.06-0.11-0.24-0.02-0.03
Sale of Property, Plant & Equipment
--0.06--
Sale (Purchase) of Intangibles
-0.03-0.1-0.12-0.12-0.17
Investing Cash Flow
-0.09-0.21-0.31-0.14-0.2
Short-Term Debt Issued
--0.026.38-
Total Debt Issued
--0.026.38-
Short-Term Debt Repaid
---2.63--
Long-Term Debt Repaid
----0.12-0.42
Total Debt Repaid
---2.63-0.12-0.42
Net Debt Issued (Repaid)
---2.616.26-0.42
Issuance of Common Stock
11.94.193.370.293.9
Other Financing Activities
-0.444.3317.9-0.02-0.05
Financing Cash Flow
11.468.5218.656.533.43
Foreign Exchange Rate Adjustments
-0.05-0.110.190.02-0
Net Cash Flow
-1.25-2.353.240.82-0.21
Free Cash Flow
-12.63-10.66-15.53-5.6-3.47
Free Cash Flow Margin
---404.03%-283.07%-175.21%
Free Cash Flow Per Share
-133.85----
Cash Interest Paid
---0.250.29
Cash Income Tax Paid
----1.18-1.24
Levered Free Cash Flow
-8.6-12.42-8.5-4.3-0.74
Unlevered Free Cash Flow
-8.6-12.37-4.28-2.15-0.56
Change in Working Capital
-2.031.54-6.7-0.230.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.